USANA Health Sciences Inc (USNA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, USANA Health Sciences Inc (USNA) has a cash flow conversion efficiency ratio of -0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.39 Million) by net assets ($586.27 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
USANA Health Sciences Inc - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how USANA Health Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of USANA Health Sciences Inc for a breakdown of total debt and financial obligations.
USANA Health Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of USANA Health Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jumbo Interactive Ltd
AU:JIN
|
0.185x |
|
NOCIL Limited
NSE:NOCIL
|
0.077x |
|
Stalprodukt SA
WAR:STP
|
0.028x |
|
Bharat Bijlee Limited
NSE:BBL
|
-0.017x |
|
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90
|
N/A |
|
Palmer Square Capital BDC Inc.
NYSE:PSBD
|
0.000x |
|
NEWRON PHARMACEUT. EO-20
F:NP5
|
N/A |
|
Beijing New Universal Science and Technology Co Ltd
SHE:300472
|
0.155x |
Annual Cash Flow Conversion Efficiency for USANA Health Sciences Inc (1995–2025)
The table below shows the annual cash flow conversion efficiency of USANA Health Sciences Inc from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see USANA Health Sciences Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $586.27 Million | $22.35 Million | 0.038x | -63.35% |
| 2024-12-31 | $586.33 Million | $60.99 Million | 0.104x | -26.78% |
| 2023-12-31 | $497.20 Million | $70.64 Million | 0.142x | -40.59% |
| 2022-12-31 | $434.47 Million | $103.90 Million | 0.239x | -22.05% |
| 2021-12-31 | $395.12 Million | $121.23 Million | 0.307x | -15.52% |
| 2020-12-31 | $441.65 Million | $160.40 Million | 0.363x | +0.79% |
| 2019-12-31 | $351.71 Million | $126.73 Million | 0.360x | -7.35% |
| 2018-12-31 | $391.15 Million | $152.12 Million | 0.389x | +14.11% |
| 2017-12-31 | $363.21 Million | $123.78 Million | 0.341x | -19.10% |
| 2016-12-31 | $325.29 Million | $137.03 Million | 0.421x | +6.14% |
| 2015-12-31 | $280.85 Million | $111.47 Million | 0.397x | -13.15% |
| 2014-12-31 | $230.16 Million | $105.19 Million | 0.457x | +20.39% |
| 2013-12-31 | $260.52 Million | $98.89 Million | 0.380x | -24.10% |
| 2012-12-31 | $185.57 Million | $92.81 Million | 0.500x | +24.06% |
| 2011-12-31 | $173.91 Million | $70.11 Million | 0.403x | -11.48% |
| 2010-12-31 | $145.17 Million | $66.11 Million | 0.455x | +4.31% |
| 2009-12-31 | $74.37 Million | $32.47 Million | 0.437x | -69.76% |
| 2008-12-31 | $31.84 Million | $45.96 Million | 1.444x | -2.52% |
| 2007-12-31 | $38.64 Million | $57.22 Million | 1.481x | +47.30% |
| 2006-12-31 | $60.20 Million | $60.52 Million | 1.005x | -4.24% |
| 2005-12-31 | $45.74 Million | $48.02 Million | 1.050x | +31.55% |
| 2004-12-31 | $47.84 Million | $38.18 Million | 0.798x | -0.19% |
| 2003-12-31 | $44.37 Million | $35.48 Million | 0.800x | -9.26% |
| 2002-12-31 | $18.09 Million | $15.94 Million | 0.881x | +28.64% |
| 2001-12-31 | $14.53 Million | $9.95 Million | 0.685x | +116.77% |
| 2000-12-31 | $12.87 Million | $4.07 Million | 0.316x | -72.82% |
| 1999-12-31 | $12.90 Million | $15.00 Million | 1.163x | +235.67% |
| 1998-12-31 | $30.60 Million | $10.60 Million | 0.346x | -5.84% |
| 1997-12-31 | $19.30 Million | $7.10 Million | 0.368x | +8.61% |
| 1996-12-31 | $12.40 Million | $4.20 Million | 0.339x | -42.68% |
| 1995-12-31 | $6.60 Million | $3.90 Million | 0.591x | -- |
About USANA Health Sciences Inc
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Ess… Read more